China NMPA Drug Inspection - Guangxi Zhongsen Traditional Chinese Medicine Pharmaceutical Co., Ltd. - Blue Sky Sunflower
China NMPA drug inspection for Guangxi Zhongsen Traditional Chinese Medicine Pharmaceutical Co., Ltd. published February 06, 2018. Drug: Blue Sky Sunflower. The Guangxi Zhuang Autonomous Region Food and Drug Administration issued its first Drug Quality Announcement of 2018 on
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Guangxi Zhongsen Traditional Chinese Medicine Pharmaceutical Co., Ltd. published February 06, 2018. Drug: Blue Sky Sunflower. The Guangxi Zhuang Autonomous Region Food and Drug Administration issued its first Drug Quality Announcement of 2018 on
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox